ABL1 and acute promyelocytic leukemia: For example, arsenic, a well known curative agent for acute promyelocytic leukemia, was shown to induce degradation of BCR-ABL by directly binding an E3, c-Cbl, and preventing its self-uiquitination/degradation54.